FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 3211069 · Received July 8, 2013

Report

Report Number
2124215-2013-08653
Event Type
Malfunction
Date Received
July 8, 2013
Date of Event
April 30, 2013
Report Date
April 30, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A RECENT DEVICE CHANGE OUT PROCEDURE IT WAS NOTED THAT THIS RIGHT ATRIAL (RA) LEAD EXHIBITED OUT-OF-RANGE (OOR) IMPEDANCES OF GREATER THAN 3000 OHMS. THE PHYSICIAN ELECTED TO ELECTRICALLY PROGRAM THE DEVICE TO VVIR. THE LEAD REMAINS IMPLANTED. TO DATE, NO ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310934 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4472

Patients

Seq Age Sex Outcome Treatment
1 84 YR A155| 4518| 4472| 0184| H215| N164